Daclizumab and disease recurrence Patient Reports February 12, 2012

Daclizumab Side Effects Report #4766444-3
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4766445-5
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4792920-3
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4797110-6
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4848404-7
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with CELLCEPT, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4848405-9
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with CELLCEPT, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4640131-4
Daclizumab side effect was reported by a Physician from on Apr 11, 2005. Male patient, 56 years of age, was diagnosed with prophylaxis, hyperglycaemia and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatic haematoma, hepatitis viral, pleural effusion, transaminases abnormal. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, PANTOPRAZOLE, MORPHINE, INSULIN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4851522-0
Daclizumab side effect was reported by a Physician from SPAIN on Apr 11, 2005. Male patient, 56 years of age, was diagnosed with prophylaxis, hyperglycaemia and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis viral. Daclizumab dosage: unknown. During the same period patient was treated with CELLCEPT, TACROLIMUS, PREDNISONE, PANTOPRAZOLE, MORPHINE, INSULINE. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4882332-6
Daclizumab side effect was reported by a Physician from CANADA on Oct 17, 2005. Female patient, 48 years of age, weighting 124.8 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: culture urine positive, disease recurrence, escherichia infection, pathogen resistance, pyelonephritis acute. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, CORTICOSTEROIDS, ACTONEL, MONOCOR, CALCIUM GLUCONATE, VITAMINE D. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4586892-4
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatic haematoma, hepatitis a , hepatitis c . Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, TACROLIMUS, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4690924-2
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, gamma-glutamyltransferase decreased, hepatic haematoma, hepatic haemorrhage, hepatitis c , hypotension, insomnia. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4917705-6
Daclizumab side effect was reported by a Physician from FRANCE on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cholestasis, disease recurrence, hepatic haematoma, hepatitis c , hypotension, insomnia, post procedural haemorrhage. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4700457-2
Daclizumab side effect was reported by a Physician from on June 16, 2005. Male patient, child 11 years of age, weighting 91.05 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal pain , blood creatinine increased, cellulitis , dehydration, disease recurrence, dysuria, epstein-barr virus infection, fatigue, fluid intake reduced. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, AZATHIOPRINE. Patient was hospitalized. Patient recovered.